Detalhe da pesquisa
1.
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature
; 608(7923): 609-617, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948633
2.
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.
Nature
; 572(7770): 538-542, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367040
3.
In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.
EMBO J
; 39(5): e102169, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930530
4.
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature
; 609(7929): E13, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050473
5.
GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice.
J Mammary Gland Biol Neoplasia
; 24(3): 271-284, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218575
6.
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
J Mammary Gland Biol Neoplasia
; 24(4): 305-321, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31729597
7.
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer.
Proc Natl Acad Sci U S A
; 112(27): 8409-14, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100884
8.
Molecular and cellular consequences of mevalonate kinase deficiency.
Biochim Biophys Acta Mol Basis Dis
; 1870(5): 167177, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636615
9.
Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Sci Rep
; 13(1): 338, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611064
10.
Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Biochim Biophys Acta
; 1811(4): 227-33, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21237288
11.
Posttranslational modification of microtubules by the MATCAP detyrosinase.
Science
; 376(6595): eabn6020, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482892
12.
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Nat Commun
; 13(1): 6579, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323660
13.
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Nat Commun
; 10(1): 397, 2019 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674894
14.
Detection of nonsterol isoprenoids by HPLC-MS/MS.
Anal Biochem
; 383(1): 18-24, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18782552
15.
TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.
Oncotarget
; 6(11): 8760-76, 2015 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25797249
16.
Using the GEMM-ESC strategy to study gene function in mouse models.
Nat Protoc
; 10(11): 1755-85, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26492136
17.
TRPM7 is required for breast tumor cell metastasis.
Cancer Res
; 72(16): 4250-61, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22871386